UBI.AX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 08:18):
Our systems believe the stock currently is overvalued by -0.11% compare to its pairs and should correct downwards.

Stats
今日成交量	42 111
平均成交量	337 415
市值	34.71M
EPS	$-0.0161 ( Q1 \| 2024-03-31 )
下一个收益日期	( $0 ) 2024-07-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.00 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

AHX.AX -2.90%

ALC.AX 6.25%

ANN.AX -2.41%

AT1.AX 0.00%

AVR.AX 0.00%

CAJ.AX -4.76%

CAU.AX 0.00%

CDX.AX -7.14%

CGS.AX -0.89%

COH.AX -2.89%

CYC.AX -6.51%

EBO.AX -1.81%

EHE.AX 0.33%

EMD.AX 12.20%

EMV.AX -11.11%

FPH.AX -1.26%

HLA.AX 0.17%

HLS.AX -4.33%

HMD.AX 13.04%

IBX.AX -1.18%

IDX.AX -3.00%

IHL.AX -10.87%

IMR.AX -0.94%

IPD.AX -1.39%

M7T.AX -0.78%

MDR.AX -5.00%

MVF.AX -3.11%

MX1.AX -3.61%

NAN.AX -4.01%

NTI.AX 1.43%

NXS.AX -6.38%

ONE.AX -3.75%

PCK.AX 3.70%

PME.AX -5.31%

PNV.AX -4.90%

PSQ.AX -0.79%

REG.AX -3.21%

RHC.AX -1.60%

RHY.AX -3.23%

RSH.AX 13.04%

SHL.AX -2.43%

SIG.AX -2.35%

SNZ.AX 0.81%

TTB.AX 0.00%

UBI.AX 0.00%

VHT.AX 0.44%

VTI.AX 0.00%

相关性 (AI algo v.1.1b): Overvalued: -0.11% $0.150 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

Universal Biosensors, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Universal Biosensors, 财务报表

Annual	2023
营收:	$6.63M
毛利润:	$3.32M (50.05 %)
EPS:	$-0.0317

FY	2023
营收:	$6.63M
毛利润:	$3.32M (50.05 %)
EPS:	$-0.0317

FY	2022
营收:	$4.52M
毛利润:	$2.14M (47.27 %)
EPS:	$-0.140

FY	2021
营收:	$5.78M
毛利润:	$2.11M (36.44 %)
EPS:	$-0.0592

Financial Reports:

No articles found.

Universal Biosensors, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Universal Biosensors,

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens' Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin. The company also manufactures and distributes Sentia SO2 test strips; and distributes Sentia Analyzer for the use in measurement of free SO2 levels in post-fermentation wine. In addition, it offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.